Clinical Trials Browser

Phase 1/2 × olorofim × Other hematologic neoplasm × Clear all

NCT02856178 2018-02-15

SAFEGUARD

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Invasive Pulmonary Aspergillosis

NCT03036046 2018-02-15

SAFEGUARDFP

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute